The melatonin receptor 1B gene links circadian rhythms and type 2 diabetes mellitus: an evolutionary story

References

• International Diabetes Federation (IDF) 2021. Available from: https://diabetesatlasorg/.
   Google Scholar
• Smushkin G, Vella A. Genetics of type 2 diabetes. Curr Opin Clin Nutr Metab Care. 2010;13(4):471–477.
   PubMed Web of Science ®Google Scholar
• Panda S. Circadian physiology of metabolism. Science. 2016;354(6315):1008–1015.
   PubMed Web of Science ®Google Scholar
• Qian J, Scheer F. Circadian system and glucose metabolism: implications for physiology and disease. Trends Endocrinol Metab. 2016;27(5):282–293.
   PubMed Web of Science ®Google Scholar
• Mason IC, Qian J, Adler GK, et al. Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia. 2020;63(3):462–472.
   PubMed Web of Science ®Google Scholar
• Shan Z, Li Y, Zong G, et al. Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses. BMJ. 2018;363:k4641.
   PubMed Web of Science ®Google Scholar
• Pan A, Schernhammer ES, Sun Q, et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011;8(12):e1001141.
   PubMed Web of Science ®Google Scholar
• Suwazono Y, Sakata K, Okubo Y, et al. Long-term longitudinal study on the relationship between alternating shift work and the onset of diabetes mellitus in male japanese workers. J Occup Environ Med. 2006;48(5):455–461.
   PubMed Web of Science ®Google Scholar
• Koopman ADM, Rauh SP, van ‘t Riet E, et al. The association between social jetlag, the metabolic syndrome, and type 2 diabetes mellitus in the general population: the new hoorn study. J Biol Rhythms. 2017;32(4):359–368.
   PubMed Web of Science ®Google Scholar
• Mota MC, Silva CM, Balieiro LCT, et al. Social jetlag and metabolic control in non-communicable chronic diseases: a study addressing different obesity statuses. Sci Rep. 2017;7(1):6358.
   PubMedGoogle Scholar
• Mokhlesi B, Temple KA, Tjaden AH, et al. Association of self-reported sleep and circadian measures with glycemia in adults with prediabetes or recently diagnosed untreated type 2 diabetes. Diabetes Care. 2019;42(7):1326–1332.
   PubMed Web of Science ®Google Scholar
• Merikanto I, Lahti T, Puolijoki H, et al. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int. 2013;30(4):470–477.
   PubMed Web of Science ®Google Scholar
• Stenvers DJ, Scheer F, Schrauwen P, et al. Circadian clocks and insulin resistance. Nat Rev Endocrinol. 2019;15(2):75–89.
   PubMed Web of Science ®Google Scholar
• Gale JE, Cox HI, Qian J, et al. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms. 2011;26(5):423–433.
   PubMed Web of Science ®Google Scholar
• Scheer FA, Hilton MF, Mantzoros CS, et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106(11):4453–4458.
   PubMed Web of Science ®Google Scholar
• Karamitri A, Jockers R. Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol. 2019;15(2):105–125.
   PubMed Web of Science ®Google Scholar
• Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res. 2008;44(1):26–40.
   PubMed Web of Science ®Google Scholar
• Tuomi T, Nagorny CLF, Singh P, et al. Increased melatonin signaling is a risk factor for type 2 diabetes. Cell Metab. 2016;23(6):1067–1077.
   PubMed Web of Science ®Google Scholar
• McMullan CJ, Schernhammer ES, Rimm EB, et al. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013;309(13):1388–1396.
   PubMed Web of Science ®Google Scholar
• McMullan CJ, Curhan GC, Schernhammer ES, et al. Association of nurnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013;178(2):231–238.
   PubMed Web of Science ®Google Scholar
• Garfinkel D, Zorin M, Wainstein J, et al. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr Obes. 2011;4:307–313.
   PubMedGoogle Scholar
• Rubio-Sastre P, Scheer FA, Gomez-Abellan P, et al. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep. 2014;37(10):1715–1719.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangino S, Renzi A, et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol (Oxf). 2001;54(3):339–346.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci. 1995;16(2):50–56.
   PubMed Web of Science ®Google Scholar
• Stein RM, Kang HJ, McCorvy JD, et al. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. Nature. 2020;579(7800):609–614
   PubMed Web of Science ®Google Scholar
• Ramracheya RD, Muller DS, Squires PE, et al. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res. 2008;44(3):273–279.
   PubMed Web of Science ®Google Scholar
• Blodgett DM, Nowosielska A, Afik S, et al. el observations from Next-Generation RNA sequencing of highly purified human adult and fetal islet cell subsets. Diabetes. 2015;64(9):3172–3181.
   PubMed Web of Science ®Google Scholar
• Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009;41(1):89–94.
   PubMed Web of Science ®Google Scholar
• Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41(1):77–81.
   PubMed Web of Science ®Google Scholar
• Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–116.
   PubMed Web of Science ®Google Scholar
• Hu C, Jia W. Linking MTNR1B variants to diabetes: the role of circadian rhythms. Diabetes. 2016;65(6):1490–1492.
   PubMed Web of Science ®Google Scholar
• Lane JM, Chang AM, Bjonnes AC, et al. Impact of common diabetes risk variant in MTNR1B on sleep, circadian, and melatonin physiology. Diabetes. 2016;65(6):1741–1751.
   PubMed Web of Science ®Google Scholar
• Imam A, Winnebeck EC, Buchholz N, et al. Circadian, sleep and caloric intake phenotyping in type 2 diabetes patients with rare melatonin receptor 2 mutations and controls: a pilot study. Front Physiol. 2020;11:564140.
   PubMed Web of Science ®Google Scholar
• Garaulet M, Lopez-Minguez J, Dashti HS, et al. Interplay of dinner timing and MTNR1B type 2 diabetes risk variant on glucose tolerance and insulin secretion: a randomized crossover trial. Diabetes Care. 2022;45(3):512–519.
   PubMed Web of Science ®Google Scholar
• Mulder H. Melatonin signalling and type 2 diabetes risk: too little, too much or just right? Diabetologia. 2017;60(5):826–829.
   PubMed Web of Science ®Google Scholar
• Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia. 2008;51(7):1100–1110.
   PubMed Web of Science ®Google Scholar
• Dietrich K, Birkmeier S, Schleinitz D, et al. Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of sorbs from Germany. Diabet Med. 2011;28(11):1373–1380.
   PubMed Web of Science ®Google Scholar
• Ji LD, Xu J, Wu DD, et al. Association of disease-predisposition polymorphisms of the melatonin receptors and sunshine duration in the global human populations. J Pineal Res. 2010;48(2):133–141.
   PubMed Web of Science ®Google Scholar
• Woelfle MA, Ouyang Y, Phanvijhitsiri K, et al. The adaptive value of circadian clocks: an experimental assessment in cyanobacteria. Curr Biol. 2004;14(16):1481–1486.
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Andersson CR, Kondo T, et al. Resonating circadian clocks enhance fitness in cyanobacteria. Proc Natl Acad Sci U S A. 1998;95(15):8660–8664.
   PubMed Web of Science ®Google Scholar
• Fagiani F, Di ino D, Romagnoli A, et al. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct Target Ther. 2022;7(1):41.
   PubMed Web of Science ®Google Scholar
• Li MD, Xin H, Yuan Y, et al. Circadian Clock-Controlled checkpoints in the pathogenesis of complex disease. Front Genet. 2021;12:721231.
   PubMed Web of Science ®Google Scholar
• Gooley JJ, Chamberlain K, Smith KA, et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011;96(3):E463–72.
   PubMed Web of Science ®Google Scholar
• Lockley SW, Brainard GC, Czeisler CA. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. 2003;88(9):4502–4505.
   PubMed Web of Science ®Google Scholar
• Cipolla-Neto J, Aal FGD. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018;39(6):990–1028.
   PubMed Web of Science ®Google Scholar
• Riggs W, Jr., Seibert J. Pseudoectopic ureter on prone urogram. Radiology. 1973;106(2):391–392.
   PubMed Web of Science ®Google Scholar
• Huang H, Wang Z, Weng SJ, et al. Neuromodulatory role of melatonin in retinal information processing. Prog Retin Eye Res. 2013;32:64–87.
   PubMed Web of Science ®Google Scholar
• Weaver DR, Stehle JH, Stopa EG, et al. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J Clin Endocrinol Metab. 1993;76(2):295–301.
   PubMed Web of Science ®Google Scholar
• Reppert SM, Weaver DR, Rivkees SA, et al. Putative melatonin receptors in a human biological clock. Science. 1988;242(4875):78–81.
   PubMed Web of Science ®Google Scholar
• Vriend J, Reiter RJ. Melatonin feedback on clock genes: a theory involving the proteasome. J Pineal Res. 2015;58(1):1–11.
   PubMed Web of Science ®Google Scholar
• Liu J, Clough SJ, Hutchinson AJ, et al. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol. 2016;56:361–383.
   PubMed Web of Science ®Google Scholar
• Gobbi G, Comai S. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep. J Pineal Res. 2019;66(3):e12544.
   PubMed Web of Science ®Google Scholar
• Zlotos DP, Jockers R, Cecon E, et al. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. J Med Chem. 24 2014;57(8):3161–3185.
   PubMed Web of Science ®Google Scholar
• Cipolla-Neto J, Aal FG, Afeche SC, et al. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014;56(4):371–381.
   PubMed Web of Science ®Google Scholar
• Genario R, Cipolla-Neto J, Bueno AA, et al. Melatonin supplementation in the management of obesity and obesity-associated disorders: a review of physiological mechanisms and clinical applications. Pharmacol Res. 2021;163:105254.
   PubMed Web of Science ®Google Scholar
• Garaulet M, Qian J, Florez JC, et al. Melatonin effects on glucose metabolism: time to unlock the controversy. Trends Endocrinol Metab. 2020;31(3):192–204.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, o JC, Tan DX, et al. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res. 2016;61(3):253–278.
   PubMed Web of Science ®Google Scholar
• Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005;9(1):11–24.
   PubMed Web of Science ®Google Scholar
• Lok R, van Koningsveld MJ, Gordijn MCM, et al. Daytime melatonin and light independently affect human alertness and body temperature. J Pineal Res. 2019;67(1):e12583.
   PubMed Web of Science ®Google Scholar
• Hardeland R. Melatonin and inflammation-story of a double-edged blade. J Pineal Res. 2018;65(4):e12525.
   PubMed Web of Science ®Google Scholar
• Pham L, Baiocchi L, Kennedy L, et al. The interplay between mast cells, pineal gland, and circadian rhythm: links between histamine, melatonin, and inflammatory mediators. J Pineal Res. 2021;70(2):e12699.
   PubMed Web of Science ®Google Scholar
• Ma N, Zhang J, Reiter RJ, et al. Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: a therapeutic target to reduce intestinal inflammation. Med Res Rev. 2020;40(2):606–632.
   PubMed Web of Science ®Google Scholar
• Sato K, Meng F, Francis H, et al. Melatonin and circadian rhythms in liver diseases: functional roles and potential therapies. J Pineal Res. 2020;68(3):e12639.
   PubMed Web of Science ®Google Scholar
• Munmun F, Witt-Enderby PA. Melatonin effects on bone: implications for use as a therapy for managing bone loss. J Pineal Res. 2021;71(1):e12749.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Portaluppi F. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 2017;33:4–16.
   PubMed Web of Science ®Google Scholar
• Ma Q, Reiter RJ, Chen Y. Role of melatonin in controlling angiogenesis under physiological and pathological conditions. Angiogenesis. 2020;23(2):91–104.
   PubMed Web of Science ®Google Scholar
• Opie LH, Lecour S. Melatonin has multiorgan effects. Eur Heart J Cardiovasc Pharmacother. 2016;2(4):258–265.
   PubMed Web of Science ®Google Scholar
• Chen HY, Chen TY, Lee MY, et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res. 2006;41(2):175–182.
   PubMed Web of Science ®Google Scholar
• Kong X, Gao R, Wang Z, et al. Melatonin: a potential therapeutic option for breast cancer. Trends Endocrinol Metab. 2020;31(11):859–871.
   PubMed Web of Science ®Google Scholar
• Su SC, Hsieh MJ, Yang WE, et al. Cancer metastasis: mechanisms of inhibition by melatonin. J Pineal Res. 2017;62(1):1–40.
   Web of Science ®Google Scholar
• Olcese JM. Melatonin and female reproduction: an expanding universe. Front Endocrinol (Lausanne). 2020;11:85.
   PubMed Web of Science ®Google Scholar
• Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients. 2021;13(10):3480.
   PubMed Web of Science ®Google Scholar
• Meyer N, Harvey AG, Lockley SW, et al. Circadian rhythms and disorders of the timing of sleep. Lancet. 2022;400(10357):1061–1078.
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Hirai K. The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 beta-cells. PLoS One. 2014;9(7):e102073.
   PubMed Web of Science ®Google Scholar
• Kemp DM, Ubeda M, Habener JF. Identification and functional characterization of melatonin mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol. 2002;191(2):157–166.
   PubMed Web of Science ®Google Scholar
• Costes S, Boss M, Thomas AP, et al. Activation of melatonin signaling promotes beta-Cell survival and function. Mol Endocrinol. 2015;29(5):682–692.
   PubMedGoogle Scholar
• Gil-Lozano M, Wu WK, tchenko A, et al. High-Fat diet and palmitate alter the rhythmic secretion of glucagon-like peptide-1 by the rodent L-cell. Endocrinology. 2016;157(2):586–599.
   PubMed Web of Science ®Google Scholar
• cheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010;466(7306):627–631.
   PubMed Web of Science ®Google Scholar
• Picinato MC, Haber EP, Carpinelli AR, et al. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J Pineal Res. 2002;33(3):172–177.
   PubMed Web of Science ®Google Scholar
• Sandu C, Liu T, Malan A, et al. Circadian clocks in rat skin and dermal fibroblasts: differential effects of aging, temperature and melatonin. Cell Mol Life Sci. 2015;72(11):2237–2248.
   PubMed Web of Science ®Google Scholar
• Reinke H, Asher G. Crosstalk between metabolism and circadian clocks. Nat Rev Mol Cell Biol. 2019;20(4):227–241.
   PubMed Web of Science ®Google Scholar
• Stephan FK, Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A. 1972;69(6):1583–1586.
   PubMed Web of Science ®Google Scholar
• Czeisler CA, Weitzman E, Moore-Ede MC, et al. Human sleep: its duration and organization depend on its circadian phase. Science. 1980;210(4475):1264–1267.
   PubMed Web of Science ®Google Scholar
• Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437(7063):1257–1263.
   PubMed Web of Science ®Google Scholar
• Herrera-Moro Chao D, Leon-Mercado L, Foppen E, et al. The suprachiasmatic nucleus modulates the sensitivity of arcuate nucleus to hypoglycemia in the male rat. Endocrinology. 2016;157(9):3439–3451.
   PubMed Web of Science ®Google Scholar
• g CM, Melanson EL, Frydendall EJ, et al. Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans. J Physiol. 1 2011;589(Pt 1):235–244.
   PubMed Web of Science ®Google Scholar
• Anothaisintawee T, Reutrakul S, Van Cauter E, et al. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev. 2016;30:11–24.
   PubMed Web of Science ®Google Scholar
• Kim TW, Jeong JH, Hong SC. The impact of sleep and circadian disturbance on hormones and metabolism. Int J Endocrinol. 2015;2015:591729. .
   PubMed Web of Science ®Google Scholar
• Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30(2):152–177.
   PubMed Web of Science ®Google Scholar
• Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005;90(5):3106–3114.
   PubMed Web of Science ®Google Scholar
• Liu PY, Lawrence-Sidebottom D, Piotrowska K, et al. Clamping cortisol and testosterone mitigates the development of insulin resistance during sleep restriction in men. J Clin Endocrinol Metab. 2021;106(9):e3436–e3448.
   PubMed Web of Science ®Google Scholar
• von Gall C, Weaver DR, Kock M, et al. Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor. Neuroreport. 000;11(9):1803–1807.
   PubMed Web of Science ®Google Scholar
• Nelson CS, ino JL, Allen CN. Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. Neuroreport. 1996;7(3):717–720.
   PubMed Web of Science ®Google Scholar
• McArthur AJ, Hunt AE, Gillette MU. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology. 1997;138(2):627–634.
   PubMed Web of Science ®Google Scholar
• Kandalepas PC, Mitchell JW, Gillette MU. Melatonin signal transduction pathways require E-box-mediated transcription of Per1 and Per2 to reset the SCN clock at dusk. PLoS One. 2016;11(6):e0157824.
   PubMed Web of Science ®Google Scholar
• Pfeffer M, Rauch A, Korf HW, et al. The endogenous melatonin (MT) signal facilitates reentrainment of the circadian system to light-induced phase advances by acting upon MT2 receptors. Chronobiol Int. 2012;29(4):415–429.
   PubMed Web of Science ®Google Scholar
• Nagy AD, Iwamoto A, Kawai M, et al. Melatonin adjusts the expression pattern of clock genes in the suprachiasmatic nucleus and induces antidepressant-like effect in a mouse model of seasonal affective disorder. Chronobiol Int. 2015;32(4):447–457.
   PubMed Web of Science ®Google Scholar
• Stumpf I, Muhlbauer E, Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res. 2008;45(3):318–327.
   PubMed Web of Science ®Google Scholar
• Peschke E, Muhlbauer E, Musshoff U, et al. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res. 2002;33(2):63–71.
   PubMed Web of Science ®Google Scholar
• Peschke E, Bahr I, Muhlbauer E. Experimental and clinical aspects of melatonin and clock genes in diabetes. J Pineal Res. 2015;59(1):1–23. .
   PubMed Web of Science ®Google Scholar
• Ha E, Yim SV, Chung JH, et al. Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res. 2006;41(1):67–72.
   PubMed Web of Science ®Google Scholar
• Shieh JM, Wu HT, Cheng KC, et al. Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-Akt-GSK3beta pathway in hepatic cells. J Pineal Res. 2009;47(4):339–344.
   PubMed Web of Science ®Google Scholar
• Altman J, Garay P, Papadimitriou A, et al. Alterations in 22Na fluxes of arterial smooth muscles of spontaneously hypertensive rats. Br J Pharmacol. 1977;59(3):496P.
   PubMed Web of Science ®Google Scholar
• Nogueira TC, Lellis-Santos C, Jesus DS, et al. Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response. Endocrinology. 2011;152(4):1253–1263.
   PubMed Web of Science ®Google Scholar
• Peschke E, Schucht H, Muhlbauer E. Long-term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both wistar and type 2-diabetic Goto-Kakizaki rats. J Pineal Res. 2010;49(4):373–381.
   PubMed Web of Science ®Google Scholar
• Peschke E, Frese T, Chankiewitz E, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res. 2006;40(2):135–143.
   PubMed Web of Science ®Google Scholar
• Oliveira AC, Andreotti S, Sertie RAL, et al. Combined treatment with melatonin and insulin improves glycemic control, white adipose tissue metabolism and reproductive axis of diabetic male rats. Life Sci. 2018;199:158–166.
   PubMed Web of Science ®Google Scholar
• Sartori C, Dessen P, Mathieu C, et al. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology. 2009;150(12):5311–5317.
   PubMed Web of Science ®Google Scholar
• Hikichi T, Tateda N, Miura T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5:655–660.
   PubMedGoogle Scholar
• Gonciarz M, Bielański W, Partyka R, et al. Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. J Pineal Res. 2013;54(2):154–161.
   PubMed Web of Science ®Google Scholar
• Kadhim HM, Ismail SH, Hussein KI, et al. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res. 2006;41(2):189–193.
   PubMed Web of Science ®Google Scholar
• Sparso T, Bonnefond A, Andersson E, et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes. 2009;58(6):1450–1456.
   PubMed Web of Science ®Google Scholar
• Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–589.
   PubMed Web of Science ®Google Scholar
• Sabatti C, Service SK, Hartikainen AL, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet. 2009;41(1):35–46.
   PubMed Web of Science ®Google Scholar
• Ronn T, Wen J, Yang Z, et al. A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia. 2009;52(5):830–833.
   PubMed Web of Science ®Google Scholar
• Liu C, Wu Y, Li H, et al. MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in chinese hans from shanghai. BMC Med Genet. 2010;11:59.
   PubMed Web of Science ®Google Scholar
• Takeuchi F, Katsuya T, Chakrewarthy S, et al. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia. 2010;53(2):299–308.
   PubMed Web of Science ®Google Scholar
• Fujita H, Hara K, Shojima N, et al. Variations with modest effects have an important role in the genetic background of type 2 diabetes and diabetes-related traits. J Hum Genet. 2012;57(12):776–779.
   PubMed Web of Science ®Google Scholar
• Palmer ND, Goodarzi MO, Langefeld CD, et al. Genetic variants associated with quantitative glucose homeostasis traits translate to type 2 diabetes in Mexican Americans: the GUARDIAN (genetics underlying diabetes in hispanics) consortium. Diabetes. 2015;64(5):1853–1866.
   PubMed Web of Science ®Google Scholar
• Ramos E, Chen G, Shriner D, et al. Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans. Diabetologia. 2011;54(4):783–788.
   PubMed Web of Science ®Google Scholar
• Liu CT, Ng MC, Rybin D, et al. Transferability and fine-mapping of glucose and insulin quantitative trait loci across populations: CARe, the candidate gene association resource. Diabetologia. 2012;55(11):2970–2984.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Zhang W, Zabaneh D, et al. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes. 2009;58(11):2703–2708.
   PubMed Web of Science ®Google Scholar
• Soranzo N, Sanna S, Wheeler E, et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59(12):3229–3239.
   PubMed Web of Science ®Google Scholar
• Kraja AT, Vaidya D, Pankow JS, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60(4):1329–1339.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Go MJ, Hu C, MAGIC consortium, et al. Large-scale genome-wide association studies in east Asians identify new genetic loci influencing metabolic traits. Nat Genet. 2011;43(10):990–995.
   PubMed Web of Science ®Google Scholar
• Kettunen J, Tukiainen T, Sarin AP, et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet. 2012;44(3):269–276.
   PubMed Web of Science ®Google Scholar
• Rasmussen-Torvik LJ, Guo X, Bowden DW, et al. Fasting glucose GWAS candidate region analysis across ethnic groups in the multiethnic study of atherosclerosis (MESA). Genet Epidemiol. 2012;36(4):384–391.
   PubMed Web of Science ®Google Scholar
• Manning AK, Hivert MF, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012;44(6):659–669.
   PubMed Web of Science ®Google Scholar
• Comuzzie AG, Cole SA, Laston SL, et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One. 2012;7(12):e51954.
   PubMed Web of Science ®Google Scholar
• Kwak SH, Kim SH, Cho YM, et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes. . 2012;61(2):531–541.
   PubMed Web of Science ®Google Scholar
• Kristiansson K, Perola M, Tikkanen E, et al. Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 2012;5(2):242–249.
   PubMedGoogle Scholar
• Morris CJ, Yang JN, Scheer F. The impact of the circadian timing system on cardiovascular and metabolic function. Prog Brain Res. 2012;199:337–358.
   PubMed Web of Science ®Google Scholar
• Go MJ, Hwang JY, Kim YJ, et al. New susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes in the korean population. J Hum Genet. 2013;58(6):362–365.
   PubMed Web of Science ®Google Scholar
• Hayes MG, Urbanek M, Hivert MF, HAPO Study Cooperative Research Group, et al. Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies. Diabetes. 2013;62(9):3282–3291.
   PubMed Web of Science ®Google Scholar
• Prokopenko I, Poon W, Magi R, et al. A Central role for GRB10 in regulation of islet function in man. PLoS Genet. 2014;10(4):e1004235.
   PubMed Web of Science ®Google Scholar
• Maha A, Go MJ, Zhang W. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46(3):234–244.
   Google Scholar
• Wessel J, Chu AY, Willems SM, et al. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun. 2015;6:5897.
   PubMed Web of Science ®Google Scholar
• Kettunen J, Demirkan A, Wurtz P, et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals el systemic effects of LPA. Nat Commun. 2016;7:11122.
   PubMed Web of Science ®Google Scholar
• Horikoshi M, Beaumont RN, Day FR, et al. Genome-wide associations for birth weight and correlations with adult disease. Nature. 2016;538(7624):248–252.
   PubMed Web of Science ®Google Scholar
• Wood AR, Jonsson A, Jackson AU, et al. A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants. Diabetes. 2017;66(8):2296–2309.
   PubMed Web of Science ®Google Scholar
• Wheeler E, Leong A, Liu CT, et al. Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis. PLoS Med. 2017;14(9):e1002383.
   PubMed Web of Science ®Google Scholar
• Zhao W, Rasheed A, Tikkanen E, Michigan Biobank, et al. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nat Genet. 2017;49(10):1450–1457.
   PubMed Web of Science ®Google Scholar
• Qi Q, Stilp AM, Sofer T, et al. Genetics of type 2 diabetes in U.S. Hispanic/latino individuals: results from the hispanic community health study/study of latinos (HCHS/SOL). Diabetes. . 2017;66(5):1419–1425.
   PubMed Web of Science ®Google Scholar
• Beaumont RN, Warrington NM, Cavadino A, et al. Genome-wide association study of offspring birth weight in 86 577 women identifies five el loci and highlights maternal genetic effects that are independent of fetal genetics. Hum Mol Genet. 2018;27(4):742–756.
   PubMed Web of Science ®Google Scholar
• Kanai M, Akiyama M, Takahashi A, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390–400.
   PubMed Web of Science ®Google Scholar
• Wu B, Pankow JS. Fast and accurate genome-wide association test of multiple quantitative traits. Comput Math Methods Med. 2018;2018:2564531.
   PubMed Web of Science ®Google Scholar
• Loomis SJ, Li M, uthur NM, et al. Genome-wide association study of serum fructosamine and glycated albumin in adults without diagnosed diabetes: results from the atherosclerosis risk in communities study. Diabetes. 2018;67(8):1684–1696.
   PubMed Web of Science ®Google Scholar
• Kichaev G, Bhatia G, Loh PR, et al. Leveraging polygenic functional enrichment to improve GWAS power. Am J Hum Genet. 2019;104(1):65–75.
   PubMed Web of Science ®Google Scholar
• Keaton JM, Gao C, Guan M, et al. Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a el type 2 diabetes susceptibility gene in african americans. Genet Epidemiol. 2018;42(6):559–570.
   PubMed Web of Science ®Google Scholar
• Bonas-Guarch S, Guindo-tinez M, Miguel-Escalada I, et al. Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes. Nat Commun. 22 2018;9(1):321.
   PubMedGoogle Scholar
• van Zuydam NR, Ahlqvist E, Sandholm N, et al. A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes. . 2018;67(7):1414–1427.
   PubMed Web of Science ®Google Scholar
• Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.
   PubMedGoogle Scholar
• Maha A, Taliun D, Thurner M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505–1513.
   PubMed Web of Science ®Google Scholar
• Masotti M, Guo B, Wu B. Pleiotropy informed adaptive association test of multiple traits using genome-wide association study sumy data. Biometrics. 2019;75(4):1076–1085.
   PubMed Web of Science ®Google Scholar
• Warrington NM, Beaumont RN, Horikoshi M, et al. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat Genet. 2019;51(5):804–814.
   PubMed Web of Science ®Google Scholar
• Wojcik GL, Graff M, Nishimura KK, et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature. 2019;570(7762):514–518.
   PubMed Web of Science ®Google Scholar
• Gallois A, Mefford J, Ko A, et al. A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context. Nat Commun. 2019;10(1):4788.
   PubMedGoogle Scholar
• Zhu Z, Guo Y, Shi H, et al. Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK biobank. J Allergy Clin Immunol. 2020;145(2):537–549.
   PubMed Web of Science ®Google Scholar
• ienne H, Lechat P, Guillemot V, et al. JASS: command line and web interface for the joint analysis of GWAS results. NAR Genom Bioinform. 2020;2(1):lqaa003.
   PubMedGoogle Scholar
• Oh SW, Lee JE, Shin E, et al. Genome-wide association study of metabolic syndrome in korean populations. PLoS One. 2020;15(1):e0227357.
   PubMed Web of Science ®Google Scholar
• Vujkovic M, Keaton JM, Lynch JA, et al. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020;52(7):680–691.
   PubMed Web of Science ®Google Scholar
• Spracklen CN, Horikoshi M, Kim YJ, et al. Identification of type 2 diabetes loci in 433,540 east asian individuals. Nature. 2020;582(7811):240–245.
   PubMed Web of Science ®Google Scholar
• Lagou V, Magi R, Hottenga JJ, et al. Sex-dimorphic genetic effects and el loci for fasting glucose and insulin variability. Nat Commun. J2021;12(1):24.
   PubMed Web of Science ®Google Scholar
• Sinnott-Armstrong N, Tanigawa Y, A D, et al. Genetics of 35 blood and urine biokers in the UK biobank. Nat Genet. 2021;53(2):185–194.
   PubMed Web of Science ®Google Scholar
• Chung RH, Chiu YF, Wang WC, et al. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose. Diabetologia. 2021;64(7):1613–1625.
   PubMed Web of Science ®Google Scholar
• Chen J, Spracklen CN, enne G, et al. The trans-ancestral genomic architecture of glycemic traits. Nat Genet. 2021;53(6):840–860.
   PubMed Web of Science ®Google Scholar
• Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415–1424.
   PubMed Web of Science ®Google Scholar
• Li-Gao R, Hughes DA, van Klinken JB, et al. Genetic studies of metabolomics change after a liquid meal illuminate el pathways for glucose and lipid metabolism. Diabetes. 2021;70(12):2932–2946.
   PubMed Web of Science ®Google Scholar
• Downie CG, Dimos SF, Bien SA, et al. Multi-ethnic GWAS and fine-mapping of glycaemic traits identify el loci in the PAGE study. Diabetologia. 2022;65(3):477–489.
   PubMed Web of Science ®Google Scholar
• DiCorpo D, Gaynor SM, Russell EM, et al. Whole genome sequence association analysis of fasting glucose and fasting insulin levels in diverse cohorts from the NHLBI TOPMed program. Commun Biol. 2022;5(1):756.
   PubMed Web of Science ®Google Scholar
• Tchio C, Musani SK, Quarshie A, et al. Association between MTNR1B polymorphisms and obesity in African American: findings from the jackson heart study. BMC Med Genomics. 2021;14(1):136.
   PubMed Web of Science ®Google Scholar
• Song JF, Zhang J, Zhang MZ, et al. Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among chinese han patients. BMC Med Genomics. 2021;14(1):156.
   PubMed Web of Science ®Google Scholar
• Tan X, Benedict C. Does the common type 2 Diabetes-Susceptibility variant in the MTNR1B gene matter for glycemic control among patients on antidiabetic pharmacotherapy? Clin Proc. 2021;96(5):1372–1374.
   Google Scholar
• Garaulet M, Gomez-Abellan P, Rubio-Sastre P, et al. Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans. Metabolism. 2015;64(12):1650–1657.
   PubMed Web of Science ®Google Scholar
• Kampmann U, Lauritzen ES, Grarup N, et al. Acute metabolic effects of melatonin – a randomized crossover study in healthy young men. J Pineal Res. 2021;70(2):e12706.
   PubMed Web of Science ®Google Scholar
• Cherrington AD. Banting lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes. 1999;48(5):1198–1214.
   PubMed Web of Science ®Google Scholar
• Magnusson I, Rothman DL, Katz LD, et al. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest. 1992;90(4):1323–1327.
   PubMed Web of Science ®Google Scholar
• Vangipurapu J, Stancakova A, Pihlajamaki J, et al. Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic finnish men. Diabetologia. 2011;54(3):563–571.
   PubMed Web of Science ®Google Scholar
• Staiger H, Machicao F, Schafer SA, et al. Polymorphisms within the el type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One. 2008;3(12):e3962.
   PubMed Web of Science ®Google Scholar
• Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41(1):82–88.
   PubMed Web of Science ®Google Scholar
• van de Bunt M, Manning Fox JE, Dai X, et al. Transcript expression data from human islets links regulatory signals from Genome-Wide association studies for type 2 diabetes and glycemic traits to their downstream effectors. PLoS Genet. 2015;11(12):e1005694.
   PubMed Web of Science ®Google Scholar
• Li Y, Wu H, Liu N, et al. Melatonin exerts an inhibitory effect on insulin gene transcription via MTNR1B and the downstream Raf1/ERK signaling pathway. Int J Mol Med. 2018;41(2):955–961.
   PubMed Web of Science ®Google Scholar
• Gaulton KJ, Ferreira T, Lee Y, et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015;47(12):1415–1425.
   PubMed Web of Science ®Google Scholar
• Bonnefond A, Clement N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012;44(3):297–301.
   PubMed Web of Science ®Google Scholar
• Zibolka J, Bazwinsky-Wutschke I, Muhlbauer E, et al. Distribution and density of melatonin receptors in human main pancreatic islet cell types. J Pineal Res. 2018;65(1):e12480.
   PubMed Web of Science ®Google Scholar
• Bahr I, Muhlbauer E, Schucht H, et al. Melatonin stimulates glucagon secretion in vitro and in vivo. J Pineal Res. 2011;50(3):336–344.
   PubMed Web of Science ®Google Scholar
• Zibolka J, Muhlbauer E, Peschke E. Melatonin influences somatostatin secretion from human pancreatic Delta-cells via MT1 and MT2 receptors. J Pineal Res. 2015;58(2):198–209.
   PubMed Web of Science ®Google Scholar
• Jonsson A, Ladenvall C, Ahluwalia TS, et al. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on alpha- and beta-cell function and insulin action in humans. Diabetes. . 2013;62(8):2978–2983.
   PubMed Web of Science ®Google Scholar
• You H, Hu J, Liu Y, et al. Risk of type 2 diabetes mellitus after gestational diabetes mellitus: a systematic review & meta-analysis. Indian J Med Res. 2021;154(1):62–77.
   PubMed Web of Science ®Google Scholar
• Pervjakova N, Moen GH, Borges MC, et al. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022;31(19):3377–3391.
   PubMed Web of Science ®Google Scholar
• Powe CE, Kwak SH. Genetic studies of gestational diabetes and glucose metabolism in pregnancy. Curr Diab Rep. 2020;20(12):69.
   PubMed Web of Science ®Google Scholar
• Liao S, Liu Y, Chen X, et al. The impact of genetic variants for different physiological characterization of type 2 diabetes loci on gestational insulin signaling in nondiabetic pregnant chinese women. Reprod Sci. 2015;22(11):1421–1428.
   PubMed Web of Science ®Google Scholar
• Vlassi M, Gazouli M, Paltoglou G, et al. The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population. Hormones (Athens). - 2012;11(1):70–76.
   PubMedGoogle Scholar
• Kim JY, Cheong HS, Park BL, et al. Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus. BMC Med Genet. 10 2011;12:82.
   PubMed Web of Science ®Google Scholar
• Huopio H, Cederberg H, Vangipurapu J, et al. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol. 2013;169(3):291–297.
   PubMed Web of Science ®Google Scholar
• Ding M, Chavarro J, Olsen S, et al. Genetic variants of gestational diabetes mellitus: a study of 112 SNPs among 8722 women in two independent populations. Diabetologia. 2018;61(8):1758–1768.
   PubMed Web of Science ®Google Scholar
• Grotenfelt NE, Wasenius NS, Rono K, et al. Interaction between rs10830963 polymorphism in MTNR1B and lifestyle intervention on occurrence of gestational diabetes. Diabetologia. 2016;59(8):1655–1658.
   PubMed Web of Science ®Google Scholar
• van Poppel MNM, Corcoy R, Hill D, DALI Core Investigator Group, et al. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial. Am J Clin Nutr. 9 2022;115(2):388–396.
   PubMed Web of Science ®Google Scholar
• Liang Z, Liu H, Wang L, et al. Maternal MTNR1B genotype, maternal gestational weight gain, and childhood obesity. Am J Clin Nutr. 1 2020;111(2):360–368.
   PubMed Web of Science ®Google Scholar
• Nisa H, Qi KHT, Leng J, et al. The circadian rhythm-related MTNR1B genotype, gestational weight gain, and postpartum glycemic changes. J Clin Endocrinol Metab. 2018;103(6):2284–2290. .
   PubMed Web of Science ®Google Scholar
• Firneisz G, Rosta K, Rigo J, et al. Identification and potential clinical utility of the MTNR1B rs10830963 core gene variant associated to endophenotypes in gestational diabetes mellitus. Front Genet. 2020;11:332.
   PubMed Web of Science ®Google Scholar
• Zhang C, Bao W, Rong Y, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update. - 2013;19(4):376–390.
   PubMed Web of Science ®Google Scholar
• Wu L, Cui L, Tam WH, et al. Genetic variants associated with gestational diabetes mellitus: a meta-analysis and subgroup analysis. Sci Rep. 29 2016;6:30539.
   PubMed Web of Science ®Google Scholar
• Vejrazkova D, Lukasova P, Vankova M, et al. MTNR1B genetic variability is associated with gestational diabetes in czech women. Int J Endocrinol. 2014;2014:508923.
   PubMed Web of Science ®Google Scholar
• Alharbi KK, Al-Sulaiman AM, Shedaid KMB, et al. MTNR1B genetic polymorphisms as risk factors for gestational diabetes mellitus: a case-control study in a single tertiary care center. Ann Saudi Med. 2019;39(5):309–318.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun CM, Hu XQ, et al. Relationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2014;4:6113.
   PubMed Web of Science ®Google Scholar
• Rosta K, Al-Aissa Z, Hadarits O, et al. Association study with 77 SNPs confirms the robust role for the rs10830963/G of MTNR1B variant and identifies two el associations in gestational diabetes mellitus development. PLoS One. 2017;12(1):e0169781.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tamura H, Kashida S, et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001;30(1):29–33.
   PubMed Web of Science ®Google Scholar
• Li C, Zhou Y, Qiao B, et al. Association between a melatonin receptor 1B genetic polymorphism and its protein expression in gestational diabetes mellitus. Reprod Sci. 2019;26(10):1382–1388.
   PubMed Web of Science ®Google Scholar
• Holzapfel C, Siegrist M, Rank M, et al. Association of a MTNR1B gene variant with fasting glucose and HOMA-B in children and adolescents with high BMI-SDS. Eur J Endocrinol. 2011;164(2):205–212.
   PubMed Web of Science ®Google Scholar
• de Luis Roman DA, Primo D, Aller R, et al. Association of the rs10830963 polymorphism in MTNR1B with fasting glucose, serum adipokine levels and components of metabolic syndrome in adult obese subjects. rs10830963 en MTNR1B con los niveles de glucosa en ayunas, de adipocitoquinas y componentes del sindrome metabolico en sujetos obesos adultos. Nutr Hosp. 2019;36(1):60–65. Asociacion del polimorfi smo
   PubMed Web of Science ®Google Scholar
• Zheng C, Dalla Man C, Cobelli C, et al. A common variant in the MTNR1b gene is associated with increased risk of impaired fasting glucose (IFG) in youth with obesity. Obesity. 2015;23(5):1022–1029.
   PubMed Web of Science ®Google Scholar
• Reinehr T, Scherag A, Wang HJ, et al. Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs10830963 and glucose levels in overweight children and adolescents. Pediatr Diabetes. 2011;12(4 Pt 2):435–441.
   PubMed Web of Science ®Google Scholar
• Firneisz G, Rosta K, Al-Aissa Z, et al. The MTNR1B rs10830963 variant in interaction with Pre-Pregnancy BMI is a pharmacogenetic ker for the initiation of antenatal insulin therapy in gestational diabetes mellitus. Int J Mol Sci. 2018;19(12):3734.
   PubMed Web of Science ®Google Scholar
• Jensen AC, Barker A, Kui M, et al. Associations of common genetic variants with age-related changes in fasting and postload glucose: evidence from 18 years of follow-up of the whitehall II cohort. Diabetes. 2011;60(5):1617–1623.
   PubMed Web of Science ®Google Scholar
• Walford GA, Green T, Neale B, et al. Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia. 2012;55(2):331–339.
   PubMed Web of Science ®Google Scholar
• Vejrazkova D, Vankova M, Vcelak J, et al. The rs10830963 polymorphism of the MTNR1B gene: association with abnormal glucose, insulin and C-peptide kinetics. Front Endocrinol (Lausanne). 2022;13:868364.
   PubMed Web of Science ®Google Scholar
• Linder K, Wagner R, Hatziagelaki E, et al. Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals. PLoS One. 2012;7(6):e38224.
   PubMed Web of Science ®Google Scholar
• Stancakova A, Kuulasmaa T, Paananen J, et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes. 2009;58(9):2129–2136.
   PubMed Web of Science ®Google Scholar
• Winkler C, Raab J, Grallert H, et al. Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes. PLoS One. 2012;7(4):e35410.
   PubMed Web of Science ®Google Scholar
• Andersen MK, Sterner M, Forsen T, et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes. Diabetologia. 2014;57(9):1859–1868.
   PubMed Web of Science ®Google Scholar
• Ahlqvist E, Storm P, Karajamaki A, et al. el subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361–369.
   PubMed Web of Science ®Google Scholar
• Neel JV, JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress”?. Am J Hum Genet. 1962;14(4):353–362.
   PubMed Web of Science ®Google Scholar
• Ayub Q, Moutsianas L, Chen Y, et al. Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes. Am J Hum Genet. 6 2014;94(2):176–185.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Inference of human population history from individual whole-genome sequences. Nature. 2011;475(7357):493–496.
   PubMed Web of Science ®Google Scholar
• Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320–323.
   PubMed Web of Science ®Google Scholar
• Helgason A, Palsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet. 2007;39(2):218–225.
   PubMed Web of Science ®Google Scholar
• Southam L, Soranzo N, Montgomery SB, et al. Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? Diabetologia. 2009;52(9):1846–1851.
   PubMed Web of Science ®Google Scholar
• Klimentidis YC, Abrams M, Wang J, et al. Natural selection at genomic regions associated with obesity and type-2 diabetes: east asians and Sub-Saharan africans exhibit high levels of differentiation at type-2 diabetes regions. Hum Genet. 2011;129(4):407–418.
   PubMed Web of Science ®Google Scholar
• Chen R, Corona E, Sikora M, et al. Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genet. 2012;8(4):e1002621.
   PubMed Web of Science ®Google Scholar
• Gibbons A. 12th international congress of human genetics. Diabetes genes line out of Africa. Science. 2011;334(6056):583.
   PubMedGoogle Scholar
• Neel JV. The "thrifty genotype" in 1998. Nutr Rev. 1999;57(5 Pt 2):S2–S9.
   PubMed Web of Science ®Google Scholar
• Reppert SM, Godson C, Mahle CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A. 995;92(19):8734–8738.
   PubMed Web of Science ®Google Scholar
• Mars G, Nourizadeh-Lillabadi R, Weltzien FA. New insights into the evolutionary history of melatonin receptors in vertebrates, with particular focus on teleosts. Front Endocrinol. 2020;11:538196.
   PubMed Web of Science ®Google Scholar
• Yoshiuchi I. Analysis of evolution and ethnic diversity at glucose-associated SNPs of circadian clock-related loci with cryptochrome 1, cryptochrome 2, and melatonin receptor 1b. Biochem Genet. 2021;59(5):1173–1184.
   PubMed Web of Science ®Google Scholar
• De Oliveira JW. [An undetermined form of chagas’ disease: medico-occupational implications]. arq bras cardiol. Forma Indeterminada da Doenca de Chagas. Implicacaoes Medico-Trabalhistas. 1990;54(2):89–91.
   Google Scholar